Risks of antipsychotic use in dementia extend beyond previous alerts, study shows

Antipsychotic use in people with dementia is associated with higher risks of a wide range of serious health outcomes compared with non-use, according to a new study from a collaboration across the Universities of Manchester, Nottingham, Edinburgh and Dundee.

FDA rejects Rocket Pharma’s ultra-rare immune disease gene therapy over manufacturing

The FDA rejected Rocket Pharmaceuticals’ gene therapy for leukocyte adhesion deficiency-I (LAD-I), requesting “limited additional” manufacturing information. The company announced the … Sign up to

June 29, 2024

FDA receives more reports of deaths linked to Philips’ recalled respiratory devices

Dive Brief: The Food and Drug Administration has received more medical device reports (MDRs) linked to Philips’ respiratory products that include reports of death, according to

February 1, 2024

Secure Data Transfer is Critical to a Successful Patient Journey

Thomas Pollard, Senior Sales Manager, Brother International Throughout an individual’s healthcare journey, they may circulate through various facilities. For example, what might begin at a primary care provider’s

December 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.